AN2 Therapeutics, Inc. (ANTX) stock

ANTXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$4.55+0.11 (+2.48%)

Close on Nov 13, 2026Market cap $171.70MP/E –Yield –

AN2 Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

AN2 Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?